losartan has been researched along with fidarestat in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, R; Chung, CH; Hong, SW; Kim, BH; Kim, JH; Kim, SH; Koh, JH; Lee, EY; Lee, MY; Nam, SM; Sung, JK; Yoo, JH | 1 |
1 other study(ies) available for losartan and fidarestat
| Article | Year |
|---|---|
Aldose reductase inhibitor ameliorates renal vascular endothelial growth factor expression in streptozotocin-induced diabetic rats.
Topics: Aldehyde Reductase; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Imidazolidines; Kidney; Losartan; Male; Rats; Rats, Sprague-Dawley; Vascular Endothelial Growth Factor A | 2010 |